Skip to main content
Top
Published in: Journal of Cancer Education 6/2021

01-12-2021 | Breast Cancer

How Do African-American Community Members’ Perceptions About Environmental Risks of Breast Cancer Compare with the Current State of the Science?

Authors: Brooks Yelton, Jamie R. Lead, Swann Arp Adams, Heather M. Brandt, Shibani Kulkarni, Kaleea R. Lewis, Delores Fedrick, John R. Ureda, Daniela B. Friedman

Published in: Journal of Cancer Education | Issue 6/2021

Login to get access

Abstract

African-American (AA) women experience higher mortality from breast cancer than any other racial group. Understanding community-held perceptions of environmental contaminants as risk factors for breast cancer can inform the development of tailored prevention and education efforts for improve health outcomes. Six focus groups were conducted with AA participants in two counties in South Carolina, and themes were identified using open and axial coding. Perceived environmental risks for breast cancer most frequently discussed by participants were compared to findings from published systematic reviews. Frequently discussed environmental risk factors by participants were deodorants containing aluminum, plastics, pesticides, and air and water pollution. While perceptions of aluminum and air pollution as risk factors did not align with the state of the science, perceived risk factors of chemicals in plastics and pesticides were found to be in alignment. There is some congruence between perceived environmental risks for breast cancer within the AA community and the current state of the science; however, there is a need to communicate information that reflects current science regarding commonly held misconceptions. Development of evidence-based, clear, and culturally appropriate messaging that reflects the current state of the science is warranted.
Literature
2.
go back to reference DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL (2019) Cancer statistics for African Americans, 2019. CA Cancer J Clin 69(3):211–233CrossRefPubMed DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL (2019) Cancer statistics for African Americans, 2019. CA Cancer J Clin 69(3):211–233CrossRefPubMed
5.
go back to reference Bergman Å, Heindel JJ, Jobling S, Kidd K, Zoeller TR, World Health Organization (2013) State of the science of endocrine disrupting chemicals 2012. World Health Organization Bergman Å, Heindel JJ, Jobling S, Kidd K, Zoeller TR, World Health Organization (2013) State of the science of endocrine disrupting chemicals 2012. World Health Organization
14.
go back to reference Keramatinia A, Hassanipour S, Nazarzadeh M, Wurtz M, Monfared AB, Khayyamzadeh M, Bidel Z, Mhrvar N, Mosavi-Jarrahi A (2016) Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 17(1):419–424CrossRefPubMed Keramatinia A, Hassanipour S, Nazarzadeh M, Wurtz M, Monfared AB, Khayyamzadeh M, Bidel Z, Mhrvar N, Mosavi-Jarrahi A (2016) Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 17(1):419–424CrossRefPubMed
35.
Metadata
Title
How Do African-American Community Members’ Perceptions About Environmental Risks of Breast Cancer Compare with the Current State of the Science?
Authors
Brooks Yelton
Jamie R. Lead
Swann Arp Adams
Heather M. Brandt
Shibani Kulkarni
Kaleea R. Lewis
Delores Fedrick
John R. Ureda
Daniela B. Friedman
Publication date
01-12-2021
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 6/2021
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01748-8

Other articles of this Issue 6/2021

Journal of Cancer Education 6/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine